Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows

doi:10.3748/wjg.v24.i24.2582

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9756)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

1833

HTML

5135

Figures (1-2)

248

Tables (1-2)

274

Sum=7490

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1006

Download

1260

Sum=2266

Jun 28, 2018 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jun 28, 2018; 24(24): 2582-2595
Published online Jun 28, 2018. doi: 10.3748/wjg.v24.i24.2582

Open in New Tab Full Size Figure Download Figure

Figure 1 Hepatocellular carcinoma cumulative occurrence rates reported by 11 studies considered in the present review. HCC: Hepatocellular carcinoma; f.u.: Follow up; NA: Not available.

Open in New Tab Full Size Figure Download Figure

Figure 2 Hepatocellular carcinoma cumulative recurrence rates reported by 17 studies considered in the present review. HCC: Hepatocellular carcinoma; f.u.: Follow up; NA: Not available.

Citation: Guarino M, Sessa A, Cossiga V, Morando F, Caporaso N, Morisco F, On behalf of the Special Interest Group on “Hepatocellular carcinoma and new anti-HCV therapies” of the Italian Association for the Study of the Liver. Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows. World J Gastroenterol 2018; 24(24): 2582-2595
URL: https://www.wjgnet.com/1007-9327/full/v24/i24/2582.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i24.2582